Status:
COMPLETED
A Study of Smoking Cessation Patterns in Participants Undergoing Lung Surgery
Lead Sponsor:
Johnson & Johnson (China) Investment Ltd.
Conditions:
Lung Neoplasms
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40-80 years
Brief Summary
The purpose of this study is to assess the current smoking status and smoking cessation attempts among smokers or recent smoking quitters during the perioperative period, to describe postoperative pul...
Eligibility Criteria
Inclusion
- Participants who have been scheduled for an elective lung surgery by the treating physician's judgement, due to the following conditions: known lung cancer, COPD, a pulmonary lesion (example. nodule, ground glass opacity) or other pulmonary conditions
- Smokers who are or were smoking on average no fewer than 5 cigarettes per day for equal or more than 3 years within 3 months prior to the scheduled surgery, or recent smoking quitters with a history of smoking on average no fewer than 5 cigarettes per day for equal or more than 3 years, who quit smoking between 3 months and 5 years prior to the scheduled surgery
- Being willing to participate the study and sign the participant informed consent form (ICF)
Exclusion
- Participants who have emergency lung surgery due to accident or injury
- Participants are not likely to be able to complete the 6-month follow-up after the lung surgery
Key Trial Info
Start Date :
May 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 9 2021
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT04313361
Start Date
May 6 2020
End Date
December 9 2021
Last Update
April 27 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital ,Capital Medical University
Beijing, China, 100053
2
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China, 510120
3
Ruijin Hospital Shanghai Jiao Tong University
Shanghai, China, 200000